Sequential changes in serum levels of individual bile acids in patients with chronic cholestatic liver disease (original) (raw)
Bile acid conjugation in early stage cholestatic liver disease before and during treatment with ursodeoxycholic acid
Andrea Crosignani, Kenneth Setchell
Clinica Chimica Acta, 1996
View PDFchevron_right
Liver transplantation in chronic cholestatic conditions
Elwyn Elias
Frontiers in Bioscience, 2012
View PDFchevron_right
Concentrations of cholestenoic acids in plasma from patients with liver disease
Göran Walldius
Journal of Lipid Research, 1989
View PDFchevron_right
Diagnostic Effectiveness of Serum Bile Acids in Liver Diseases as Evaluated by Multivariate Statistical Methods
Francesco Rucci
Hepatology, 2007
View PDFchevron_right
Medical Management of Chronic Cholestatic Liver Diseases
Keith Lindor
Canadian Journal of Gastroenterology, 2000
View PDFchevron_right
An update on the management of cholestatic liver diseases
Yiannis Kallis
2020
View PDFchevron_right
Diagnostic and therapeutic approach to cholestatic liver disease
Guillermo Cacho
Revista Espanola De Enfermedades Digestivas, 2004
View PDFchevron_right
A prognostic model for the outcome of liver transplantation in patients with cholestatic liver disease
Jorge L Rakela, MD, MACP, FAASLD, FACG, AGAF, Goran Klintmalm, Jeffrey Crippin
Hepatology, 1997
View PDFchevron_right
Biliary lipid secretion in chronic cholestatic liver disease
Antero Kesaniemi
Gut, 1982
View PDFchevron_right
Plasma antioxidant levels in chronic cholestatic liver diseases
Diego Martines
Alimentary Pharmacology and Therapeutics, 2000
View PDFchevron_right
Development, validation, and application of a single-tube radioimmunoassay for cholic and chenodeoxycholic conjugated bile acids in human serum
Aldo Roda
Clinical Chemistry, 1977
View PDFchevron_right
Cholestatic liver diseases: new targets, new therapies
Cynthia Levy
Therapeutic Advances in Gastroenterology, 2018
View PDFchevron_right
Altered bile acid metabolism in primary biliary cirrhosis
Bernhard Lauterburg
Digestive Diseases and Sciences, 1981
View PDFchevron_right
Bile acid-induced necrosis in primary human hepatocytes and in patients with obstructive cholestasis
Hartmut Jaeschke
Toxicology and applied pharmacology, 2015
View PDFchevron_right
Bile Acid Synthesis Disorders in Japan: Long-Term Outcome and Chenodeoxycholic Acid Treatment
Akira Ohtake
Digestive Diseases and Sciences, 2021
View PDFchevron_right
The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids
Prasanna K. Santhekadur
Hepatology (Baltimore, Md.), 2017
View PDFchevron_right
Current concepts of hepatic uptake, intracellular transport and biliary secretion of bile acids: Physiological basis and pathophysiological changes in cholestatic liver dysfunction
Professor Samy Azer
Journal of Gastroenterology and Hepatology, 1996
View PDFchevron_right
The canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis
Laurence Blendis
Hepatology, 1994
View PDFchevron_right
Predictors for incomplete response to ursodeoxycholic acid in primary biliary cholangitis. Data from a national registry of liver disease
José Presa
United European Gastroenterology Journal, 2021
View PDFchevron_right
Cholestatic Liver Disease Related to Systemic Disorders
Kimberly Forde
Cholestatic Liver Disease, 2008
View PDFchevron_right
Absence of glycochenodeoxycholic acid (GCDCA) in human bile is an indication of cholestasis: a 1H MRS study
omkar ijare, Urban Arnelo, Ian Smith
NMR in biomedicine, 2009
View PDFchevron_right
Ursodeoxycholic acid in chronic liver disease
Maria Petroni
Gut, 1991
View PDFchevron_right
Bile acid-mediated signaling in cholestatic liver diseases
Huiping Zhou
Cell & Bioscience
View PDFchevron_right
Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis
Andrew Mason
Journal of Hepatology, 2019
View PDFchevron_right
A study on changes of liver function test in Choledocholithiasis
IOSR Journals
View PDFchevron_right
Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis
Marlyn Mayo
Gut, 2019
View PDFchevron_right
Effect of cholestyramine on bile acid kinetics in patients with portal cirrhosis of the liver
Bo Angelin
The American Journal of Digestive Diseases, 1978
View PDFchevron_right
Hepatolithiasis and cholesterol and bile acid metabolism
Francesco Cetta
Gastroenterology, 1996
View PDFchevron_right
Serum bile acid analysis
Kenneth Setchell
Clinica Chimica Acta, 1983
View PDFchevron_right
The relative expression of hepatocellular and cholestatic liver enzymes in adult patients with liver disease
Юлия Юханова
Annals of Hepatology, 2019
View PDFchevron_right